Empagliflozin improves cardiovascular and renal outcomes in patients with preserved ejection fraction irrespective of age: insights from the EMPEROR-Preserved trial

被引：0
|
作者：
Boehm, Michael [1 ]
Butler, J. [2 ]
Filippatos, G. [3 ]
Ferreira, J. P. [4 ]
Pocock, S. J. [5 ]
Abdin, A. [1 ]
Mahfoud, F. [1 ]
Brueckmann, M. [6 ]
Gollop, N. D. [6 ]
Iwata, T. [7 ]
Ponikowski, P. [8 ]
Wanner, C. [9 ]
Zannad, F. [4 ]
Packer, M. [10 ]
Anker, S. D. [11 ]
机构：
[1] Univ Hosp Saarland, Clin Internal Med 3, Cardiol Angiol & Intens Care Med, Homburg, Germany
[2] Univ Mississippi, Med Ctr, Dept Med, Jackson, MS 39216 USA
[3] Natl & Kapodistrian Univ Athens, Med Sch, Athens, Greece
[4] Univ Lorraine, INSERM, Ctr Invest Clin Plurithemat, CICP 1433, Nancy, France
[5] London Sch Hyg & Trop Med, Dept Med Stat, London, England
[6] Boehringer Ingelheim Int, Ingelheim, Germany
[7] Boehringer Ingelheim GmbH & Co KG, Ingelheim, Germany
[8] Wroclaw Med Univ, Wybrzeze L Pasteura 1, PL-50367 Wroclaw, Poland
[9] Univ Hosp Wurzburg, Wurzburg, Germany
[10] Baylor Univ, Med Ctr, Dallas, TX USA
[11] German Ctr Cardiovasc Res DZHK, Berlin Inst Hlth Ctr Regenerat Therapies, Dept Cardiol BCRT, Partner Site Berlin, Berlin, Germany
来源：
EUROPEAN JOURNAL OF HEART FAILURE | 2022年 / 24卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：131 / 132
页数：2
相关论文
共 50 条
  • [31] Heart failure outcomes according to heart rate and effects of empagliflozin in patients of the EMPEROR-Preserved trial
    Boehm, Michael
    Butler, Javed
    Mahfoud, Felix
    Filippatos, Gerasimos
    Ferreira, Joao Pedro
    Pocock, Stuart J.
    Slawik, Jonathan
    Brueckmann, Martina
    Linetzky, Bruno
    Schueler, Elke
    Wanner, Christoph
    Zannad, Faiez
    Packer, Milton
    Anker, Stefan D.
    [J]. EUROPEAN JOURNAL OF HEART FAILURE, 2022, 24 (10) : 1883 - 1891
  • [32] Drug treatment with empagliflozin was beneficial in people with heart failure with preserved ejection fraction: plain language summary of the EMPEROR-Preserved study
    Zannad, Faiez
    Macari, Steven
    [J]. FUTURE CARDIOLOGY, 2023, 19 (14) : 671 - 677
  • [33] Empagliflozin and risk of lower respiratory tract infection in heart failure with mildly reduced and preserved ejection fraction: An EMPEROR-Preserved analysis
    Ferreira, Joao Pedro
    Zannad, Faiez
    Packer, Milton
    Filippatos, Gerasimos
    Pocock, Stuart J.
    Vasques-Novoa, Francisco
    Boehm, Michael
    Butler, Javed
    Anker, Stefan
    [J]. EUROPEAN JOURNAL OF HEART FAILURE, 2024, 26 (04) : 952 - 959
  • [34] Public Health Impact and Cost-Effectiveness of Empagliflozin (JARDIANCE®) in the Treatment of Patients with Heart Failure with Preserved Ejection Fraction in France, Based on the EMPEROR-Preserved Clinical Trial
    Fauchier, Laurent
    Lamblin, Nicolas
    Tardu, Jean
    Bellier, Lucile
    Groyer, Harinala
    Ittah, Deborah
    Chollet, Julien
    Linden, Stephan
    Levy, Pierre
    [J]. PHARMACOECONOMICS-OPEN, 2024, 8 (01) : 19 - 30
  • [35] Letter by Gronda et al Regarding Article, "Effect of Empagliflozin on Worsening Heart Failure Events in Patients With Heart Failure and Preserved Ejection Fraction: EMPEROR-Preserved Trial"
    Gronda, Edoardo
    Colivicchi, Furio
    Zuccala, Giuseppe
    [J]. CIRCULATION, 2022, 145 (16) : E839 - E840
  • [36] Public Health Impact and Cost-Effectiveness of Empagliflozin (JARDIANCE®) in the Treatment of Patients with Heart Failure with Preserved Ejection Fraction in France, Based on the EMPEROR-Preserved Clinical Trial
    Laurent Fauchier
    Nicolas Lamblin
    Jean Tardu
    Lucile Bellier
    Harinala Groyer
    Deborah Ittah
    Julien Chollet
    Stephan Linden
    Pierre Levy
    [J]. PharmacoEconomics - Open, 2024, 8 : 19 - 30
  • [37] Biomarker-driven prognostic models in chronic heart failure with preserved ejection fraction: the EMPEROR-Preserved trial
    Pocock, Stuart J.
    Ferreira, Joao Pedro
    Packer, Milton
    Zannad, Faiez
    Filippatos, Gerasimos
    Kondo, Toru
    McMurray, John J., V
    Solomon, Scott D.
    Januzzi, James L.
    Iwata, Tomoko
    Salsali, Afshin
    Butler, Javed
    Anker, Stefan D.
    [J]. EUROPEAN JOURNAL OF HEART FAILURE, 2022, 24 (10) : 1869 - 1878
  • [38] Design and rationale of the EMPagliflozin outcomE tRial in patients with chrOnic heaRt failure (EMPEROR-Preserved)
    Butler, J.
    Packer, M.
    Filippatos, G.
    Zannad, F.
    Salsali, A.
    Kimura, K.
    Schnee, J.
    Zeller, C.
    Pocock, S.
    George, J.
    Brueckmann, M.
    Anker, S. D.
    [J]. EUROPEAN JOURNAL OF HEART FAILURE, 2018, 20 : 232 - 232
  • [39] Efficacy of empagliflozin in heart failure with preserved versus mid-range ejection fraction: a pre-specified analysis of EMPEROR-Preserved
    Stefan D. Anker
    Javed Butler
    Muhammad Shariq Usman
    Gerasimos Filippatos
    João Pedro Ferreira
    Edimar Bocchi
    Michael Böhm
    Hans Pieter Brunner-La Rocca
    Dong-Ju Choi
    Vijay Chopra
    Eduardo Chuquiure
    Nadia Giannetti
    Juan Esteban Gomez-Mesa
    Stefan Janssens
    James L. Januzzi
    José R. González-Juanatey
    Bela Merkely
    Stephen J. Nicholls
    Sergio V. Perrone
    Ileana L. Piña
    Piotr Ponikowski
    Michele Senni
    David Sim
    Jindrich Spinar
    Iain Squire
    Stefano Taddei
    Hiroyuki Tsutsui
    Subodh Verma
    Dragos Vinereanu
    Jian Zhang
    Tomoko Iwata
    Janet M. Schnee
    Martina Brueckmann
    Stuart J. Pocock
    Faiez Zannad
    [J]. Nature Medicine, 2022, 28 : 2512 - 2520
  • [40] Efficacy of empagliflozin in heart failure with preserved versus mid-range ejection fraction: a pre-specified analysis of EMPEROR-Preserved
    Anker, Stefan D.
    Butler, Javed
    Usman, Muhammad Shariq
    Filippatos, Gerasimos
    Ferreira, Joao Pedro
    Bocchi, Edimar
    Bohm, Michael
    Brunner-La Rocca, Hans Pieter
    Choi, Dong-Ju
    Chopra, Vijay
    Chuquiure, Eduardo
    Giannetti, Nadia
    Gomez-Mesa, Juan Esteban
    Janssens, Stefan
    Januzzi, James L.
    Gonzalez-Juanatey, Jose R.
    Merkely, Bela
    Nicholls, Stephen J.
    Perrone, Sergio V.
    Pina, Ileana L.
    Ponikowski, Piotr
    Senni, Michele
    Sim, David
    Spinar, Jindrich
    Squire, Iain
    Taddei, Stefano
    Tsutsui, Hiroyuki
    Verma, Subodh
    Vinereanu, Dragos
    Zhang, Jian
    Iwata, Tomoko
    Schnee, Janet M.
    Brueckmann, Martina
    Pocock, Stuart J.
    Zannad, Faiez
    [J]. NATURE MEDICINE, 2022, 28 (12) : 2512 - +
12345